A Diagnostic accuracy and mechanical ventilation risk in Guillain-Barré syndrome

Authors

DOI:

https://doi.org/10.34024/rnc.2022.v30.13973

Keywords:

Guillain Barre Syndrome, Mechanical Ventilation, causality

Abstract

Introduction. Guillain-Barré syndrome (GBS) can assume regional variations based on antecedent illness exposure, clinical manifestations, and prognosis. Nonetheless, evidence of GBS heterogeneity in Brazil is still lacking. Objective. To determine GBS characteristics including predisposing factors, diagnostic accuracy, risk of mechanical ventilation and compare the results with other regional and international epidemiological studies. Method. In this retrospective cross-sectional study, we conducted a documental search for patients treated for GBS. After the assessment of diagnostic reliability using Brighton Criteria, data were collected using medical record review by expert neurologists. We compared predicted risk for mechanical ventilation using the Erasmus GBS Respiratory Insufficiency Score (EGRIS) and patient observed outcome within the first week. Results. In all, 33 patients were included, with reasonable diagnostic accuracy in most patients (75%). 15.2% of patients required mechanical ventilation. There was a positive association (p=0.013) between non-high risk and the absence of need for mechanical ventilation. The most common immune trigger was gastroenteritis (30.3%), followed by upper airway infection (15.2%). Conclusions. This study provides the first evidence that EGRIS may be used to identify patients with low risk for mechanical ventilation in a Brazilian sample. Prospective cohort studies are needed to confirm this finding.  Clinical and epidemiological characteristics of patients are consistent with other Latin America observational studies, except on the predominance of gastroenteritis as a major immune trigger, as also observed in Brazilian Federal District, in Lima and Bangladesh.

Metrics

Metrics Loading ...

References

Willison HJ, Jacobs BC, Doorn PA Van. Guillain-Barré syndrome. Lancet 2016;388:717-27. https://doi.org/10.1016/S0140-6736(16)00339-1

Wijdicks EFM, Klein CJ. Guillain-Barré Syndrome. Mayo Clin Proc 2017;92:467-79. https://doi.org/10.1016/j.mayocp.2016.12.002

Donofrio PD. Guillain-Barré Syndrome. Contin (Minneap Minn) 2017;23:1295-309. https://doi.org/10.1212/CON.0000000000000513

Van Den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, Van Doorn PA. Guillain-Barré syndrome: Pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 2014;10:469-82. https://doi.org/10.1038/nrneurol.2014.121

Esposito S, Longo MR. Autoimmunity Reviews Guillain – Barré syndrome. Autoimmun Rev 2017;16:96-101. http://doi.org/10.1016/j.autrev.2016.09.022

Walgaard C, Lingsma HF, Ruts L, Van Doorn PA, Steyerberg EW, Jacobs BC. Early recognition of poor prognosis in Guillain-Barré syndrome. Neurology 2011;76:968-75. https://doi.org/10.1212/WNL.0b013e3182104407

Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, et al. Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol 2019;15:671-83. https://doi.org/10.1038/s41582-019-0250-9

Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med 2020;382:2574-6. https://doi.org/10.1056/NEJMc2009191

Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 2020;19:383-4. https://doi.org/10.1016/S1474-4422(20)30109-5

Wakerley BR, Uncini A, Yuki N. Guillain-Barré and miller fisher syndromes - New diagnostic classification. Nat Rev Neurol 2014;10:537-44. https://doi.org10.1038/nrneurol.2014.138

McGrogan A, Madle GC, Seaman HE, De Vries CS. The epidemiology of Guillain-Barré syndrome worldwide: A systematic literature review. Neuroepidemiology 2009;32:150-63. https://doi.org/10.1159/000184748

Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, et al. Regional variation of Guillain-Barré syndrome. Brain 2018;141:2866-77. https://doi.org/10.1093/brain/awy232

Wong AHY, Umapathi T, Shahrizaila N, Chan YC, Kokubun N, Fong MK, et al. The value of comparing mortality of Guillain-Barré syndrome across different regions. J Neurol Sci 2014;344:60-2. https://doi.org/10.1016/j.jns.2014.06.021

Fokke C, Van Den Berg B, Drenthen J, Walgaard C, Van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain 2014;137:33-43. https://doi.org/10.1093/brain/awt285

Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, et al. Guillain-Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2011;29:599-612. https://doi.org/10.1016/j.vaccine.2010.06.003

Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain‐Barré syndrome. Ann Neurol 1990;27:S21-4. https://doi.org/10.1002/ana.410270707

Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: A systematic review and meta-analysis. Neuroepidemiology 2011;36:123-33. https://doi.org/10.1159/000324710

Dias-Tosta E, Kückelhaus CS. Guillain barré syndrome in a population less than 15 years old in Brazil. Arq Neuropsiquiatr 2002;60:367-73. https://doi.org/10.1590/S0004-282X2002000300005

Guimarães Rocha MS, Dozzi Brucki SM, De Siqueira Carvalho AA, Poti Lima ÚW. Epidemiologic features of Guillain-Barré syndrome in São Paulo, Brazil. Arq Neuropsiquiatr 2004;62:33-7. https://doi.org/10.1590/s0004-282x2004000100006

Dourado ME, Félix RH, da Silva WKA, Queiroz JW, Jeronimo SMB. Clinical characteristics of Guillain-Barré syndrome in a tropical country: A Brazilian experience. Acta Neurol Scand 2012;125:47-53. https://doi.org/10.1111/j.1600-0404.2011.01503.x

Oliveira DRCAB, Fernandez RNM, Grippe TC, Baião FS, Duarte RL, Fernandez DJ. Epidemiological and clinical aspects of Guillain-Barré syndrome and its variants. Arq Neuropsiquiatr 2021;79:497-503. https://doi.org/10.1590/0004-282X-ANP-2020-0314

Velásquez-Rimachi V, López-Saavedra AV, Rodriguez-López E, Elguera-Huaman H, Meza K, Alva-Díaz C, et al. Clinical-epidemiological characteristics associated with discharge outcomes and seasonality among surviving patients with Guillain-Barré syndrome in a national third-level Hospital, Lima, Perú. Arq Neuropsiquiatr 2021;79:697-704. https://doi.org/10.1590/0004-282X-ANP-2020-0154

Styczynski AR, Malta JMAS, Krow-Lucal ER, Percio J, Nóbrega ME, Vargas A, et al. Increased rates of Guillain-Barré syndrome associated with Zika virus outbreak in the Salvador metropolitan area, Brazil. PLoS Negl Trop Dis 2017;11:1-13. https://doi.org/10.1371/journal.pntd.0005869

Araujo LM, Ferreira MLB, Nascimento OJM. Síndrome de Guillain-Barré associada ao surto de infecção por vírus Zika no Brasil. Arq Neuropsiquiatr 2016;74:253-5. https://doi.org/10.1590/0004-282X20160035

Angelo JR, Fuller TL, Leandro BBS, Praça HLF, Marques RD, Ferreira JMC, et al. Neurological complications associated with emerging viruses in Brazil. Int J Gynecol Obstet 2020;148:70-5. https://doi.org/10.1002/ijgo.13050

Leonhard SE, Conde RM, Gondim FAA, Jacobs BC. Diagnosis and treatment of Guillain-Barré syndrome during the Zika virus epidemic in Brazil: A national survey study. J Peripher Nerv Syst 2019;24:340-7. https://doi.org/10.1111/jns.12358

Keesen TSL, Almeida RP, Gois BM, Peixoto RF, Pachá ASC, Vieira FCF, et al. Guillain-Barré syndrome and arboviral infection in Brazil. Lancet 2017;17:693-4. https://doi.org/10.1016/S1473-3099(17)30333-X

Vucic S, Kiernan MC, Cornblath DR. Guillain-Barré syndrome: An update. J Clin Neurosci 2009;16:733-41. https://doi.org/10.1016/j.jocn.2008.08.033

Walgaard C, Lingsma HF, Ruts L, Van Doorn PA, Steyerberg EW, Jacobs BC. Early recognition of poor prognosis in Guillain-Barré syndrome. Neurology 2011;76:968-75. https://doi.org/10.1212/WNL.0b013e3182104407

Published

2022-12-29

Issue

Section

Artigos Originais

How to Cite

1.
Rabello F de APCJ, Pupe CCB, Jurno ME, Monteiro Júnior RS, Carneiro LSR de SF, Nascimento OJM. A Diagnostic accuracy and mechanical ventilation risk in Guillain-Barré syndrome. Rev Neurocienc [Internet]. 2022 Dec. 29 [cited 2025 Dec. 15];30:1-19. Available from: https://periodicos.unifesp.br/index.php/neurociencias/article/view/13973
Received 2022-06-03
Accepted 2022-12-21
Published 2022-12-29